Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders (‘Code’), Eiko Lifesciences has informed that the trading window for dealing in the securities of the Company shall remain close from Today Friday, May 12, 2023 till 48 hours from conclusion of Right Issue Committee meeting to be held on Monday, May 15, 2023, to consider and determine the terms and conditions of the rights issue including the rights entitlement ratio, the issue price, number of calls to be made and other matters incidental or connected.
The above information is a part of company’s filings submitted to BSE.